Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1971322 | Clinical Biochemistry | 2008 | 4 Pages |
Abstract
ObjectivesTo identify the molecular lesion in a patient with analbuminemia.Design and methodsDNA sequencing, genome-wide SNP microarray and synthetic peptide assays to investigate DNA and protein aberrations.ResultsA homozygous frameshift deletion in exon 12 of HSA is predicted to cause truncation of the albumin protein. A proalbumin-like sequence identified in the novel C-terminal sequence has the potential to be post-translationally modified.ConclusionsThe truncated albumin molecule is potentially edited by proteolytic cleavage before it enters the circulation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ryan L. Davis, Theodore Peters Jr., Stephen O. Brennan,